Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5)-Reference-Cited by-同舟云学术

Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5)

Published:2016-05 Issue:5 Volume:16 Page:606-617
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Mallet Vincent,van Bömmel Florian,Doerig Christopher,Pischke Sven,Hermine Olivier,Locasciulli Anna,Cordonnier Catherine,Berg Thomas,Moradpour Darius,Wedemeyer Heiner,Ljungman Per

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference146 articles.

1. The EBMT activity survey: 1990–2010;Passweg;Bone Marrow Transplant,2012

2. Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015;Sureda;Bone Marrow Transplant,2015

3. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer;Lancet,2015

4. Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association;Hope;Epidemiol Infect,2014

5. American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases;Artz;J Clin Oncol,2010

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of infections for patient treated with ibrutinib in clinical practice;Frontiers in Oncology;2024-09-10

2. The liver in haematologic oncologic disorders;Journal of Hepatology;2024-09

3. Overview of infectious complications among CAR T- cell therapy recipients;Frontiers in Oncology;2024-07-03

4. Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management After Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies;Transplantation and Cellular Therapy;2024-07

5. Prevention and management of infectious complications in patients with chronic lymphocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelines;Blood Reviews;2024-05